Dr Anna Roca is an infectious disease epidemiologist with significant experience leading research groups in Southern and Western Africa.
She has served in several international pneumonia experts groups; including WHO, BMGF, Global Burden of Disease, and Decade of Vaccines. Dr Roca’s main research priorities are to understand how bacteria are transmitted to the neonates and design novel interventions to block neonatal transmission.
She leads an independent group of research focused on the use of azithromycin to prevent maternal and neonatal sepsis as well as evaluating its effects on azithromycin resistance. She is also working on how the implementation of public health interventions, such as vaccines, modify the dynamics of bacterial transmission.